• Vk
  • LinkedIn
  • Youtube
X7 Research
  • News
  • Registration strategy and Сonsulting
    • Budgeting
    • Registration strategy development
    • Study feasibility
    • Vendor selection
    • Data search and analysis
  • Clinical trials
    • Outsourcing CRAs in Russia and the EAEU
    • Development of medical documentation and biostatistics
    • Monitoring
    • Data-management
    • Patient home visits
    • Bioequivalence study
    • Therapeutic equivalence studies
    • Clinical trials of medical devices
  • Registration
    • Audit of the registration dossier
    • Bringing the registration dossier in compliance with the requirements of the EAEU
    • Conversion of registration dossier into XML format
    • PIL readability user testing
    • Translation of the Registration dossier
    • Turnkey registration
  • Post-authorization clinical studies
    • Phase IV studies
    • Non-interventional studies
    • Investigator-initiated studies
    • Post-authorisation safety study
    • Marketing research
  • Pharmacovigilance
    • QPPV in the EAEU
    • Safety monitoring of medical devices
    • Building a pharmacovigilance system
    • Safety in clinical trials
    • Pharmacovigilance audit
    • Pharmacovigilance contact person
  • Therapeutic expertise
    • Clinical trials in Oncology in the EAEU
  • Contact
  • EnglishEnglish
    • РусскийРусский
  • Menu

Bibliometric Wars

04.07.2017/in News /by eugeneqqq

Errors in bibliographic citations are very frequent in medical articles. Although such errors may seem not important, they lower citation index of articles, affecting recognition and professional advancement of an academician.

Researchers from New York University Langone Medical Center conducted analysis to highlight inaccurate and inconsistent bibliometric reports across databases. Authors searched listings of 1469 clinical and research faculty members according to their full names in the PubMed, Web of Science, Scopus, and Google Scholar databases. Google Scholar showed the highest number of publications per author, followed by Web of Science, Scopus, and PubMed. To fight such discrepancies, they offer use of Open Researcher and Contributor ID (ORCID), which can be integrated into all databases for consistency. Researchers conclude that most accurate resource to calculate an academician’s bibliometric profile has not emerged yet. These researchers clearly perceive scientists as victims of citation race.

The opposite opinion expressed Mario Biagioli, a professor of law and of science and technology studies at the University of California, Davis states that article metrics became the main reason to write an article for scientists and publishers. He claims that a new kind of metrics-enabled fraud, which he calls “post-production misconduct” has emerged. The scientific part of new publications is not polluted by false results, but metrics are regularly abused. News about research now includes regular reports of authors who supply fake e-mail addresses of suggested peer reviewers. They then use those addresses to offer reports that are supportive enough to ensure that the paper is published. ‘Review and citation’ rings go a step further, trading favorable fake reviews for citations to the reviewer’s work.

Overall, tense citations issue does not compromise pharma industry functioning directly but we should keep in mind that scientists that serve as Key Opinion Leaders do need these high citation indexes, and this should be accounted for as a certain risk factor. Regulatory bodies should be kept calm and do not worry about potential fraud in registration dossiers with regards to fake or incorrect citations. That’s why pharma industry should pay attention to various citation errors and potential fraud and possibly even develop a collaboration network to identify such impurities on a global scale.

Sources:

http://www.nejm.org/doi/full/10.1056/NEJMc1616626?query=featured_home

http://www.nature.com/news/watch-out-for-cheats-in-citation-game-1.20246

Share this entry
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail

YOU MAY ALSO BE INTERESTED IN

Publications
Readability User Testing of Package Information Leaflets (PIL) in EAEU
Read More
Publications
Remote clinical trial monitoring
Read More
Publications
Post-authorization studies of drug safety in Russia
Read More

RUBRICS

Registration strategy and Сonsulting

Clinical trials

Registration

Post-authorization clinical studies

Pharmacovigilance

LATEST PUBLICATIONS

  • Corrections to clinical trial documents due to COVID-19. Russian experience.
  • WHAT IS BIOEQUIVALENCE
  • THE VOLUME OF RUSSIAN PHARMACEUTICAL MARKET 2016-2019

Tags

bioequivalenceClinical trials in the CISfeasibilitymonitoringRadiopharmaceuticals

CONTACT

0 + 5 = ?

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.

PRIVACY

Use of this site constitutes your consent to our Privacy Policy.


SOCIAL RESPONSIBILITY

X7 Research’s primary responsibility is to help our clients in bringing medicines & products to the market efficiently and safely.

The Best CRO for Clinical Trials | Full-service Global CRO — X7 Research

The Best CRO in Pharma | Clinical Research Organisation — X7 Research

The Best Contract Research Organisation (CRO) | Trusted CRO — X7 Research

The Best Clinical Research Organisation (CRO): Full Service CRO | X7 Research

The Best CRO in Research | Trusted CRO for Your Trail — X7 Research

The Best Clinical Trial Company | Global Full-service CRO - X7 Research

The Best Pharma CROs: Clinical Trials for Drugs | X7 Research

The Best CROs Company: Clinical Trials with Global CRO — X7 Research

The Best Pre-clinical CRO: Safety Assessment With X7 Research

The Best Clinical Development | Trusted CRO for Your Product: X7 Research

The Best Biostatistical Consulting: Statistical Services | X7 Research

The Best Pharmacovigilance Consulting Services | CRO — X7 Research

Feasibility in Clinical Trials: What is a Feasibility in Clinical Trials?

Clinical Study Trials: What are Clinical Study Trials?

Category
Strategy and consulting
Clinical trials
Registration
Post-authorization clinical studies
Pharmacovigilance

Registration strategy and Сonsulting
Registration strategy development
Budgeting
Study feasibility
Vendor selection
Data search and analysis

Clinical trials
Development of medical documentation and biostatistics
Monitoring
Data management
Patient home visits
Bioequivalence study
Therapeutic equivalence studies

Registration
Audit of the registration dossier
Dossier eaeu
Conversion of registration dossier into xml format
Pil readability user testing
Turnkey registration

Post-authorization clinical studies
Phase iv studies
Non interventional studies
Investigator initiated studies
Post authorisation safety study
Marketing research

Pharmacovigilance
Building a pharmacovigilance system
Safety in clinical trials
Pharmacovigilance audit
Pharmacovigilance contact person

Blog
Contacts

© Copyright 2010-2023 - X7 Research. All rights reserved.
Pharm community is not yet ready for union EurAsEC market Serious changes in Stada
Scroll to top